Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter studyKaili Yang, Yunbo Zhao, Qin Li et al.|Cancer Immunology Immunotherapy|2021Cited by 30
Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study.Kaili Yang, Lin Zhao, Lu Han et al.|Journal of Clinical Oncology|2021Cited by 1